News
Treating a rare cancer using a precision medicine approach
6 Oct 2021
Cambridge clinical researchers have, for the first time, shown that the drug nirogacestat can be effective in treating a rare type of cancer arising from the windpipe (trachea).
ELEVATE immunotherapy trial opens
28 Sep 2021
An Addenbrooke’s doctor is leading a trial to find improved treatments for patients with advanced oesophagogastric (OG) cancer.
Targeted low-dose radiotherapy may help drugs reach brain tumours
5 Jun 2017
Promising early trial results indicate that a targeted low dose of radiotherapy may help cancer drugs reach brain tumours.
£226 million UK investment in cancer research announced
1 Dec 2016
Cambridge to benefit from largest investment to date by Cancer Research UK - £190 million across 13 Cancer Centres.